Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05252390
Title NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nuvation Bio Inc.

prostate cancer

Advanced Solid Tumor

ovarian cancer

peritoneum cancer

fallopian tube cancer

pancreatic cancer

triple-receptor negative breast cancer



NUV-868 + Olaparib

Enzalutamide + NUV-868

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.